Status:
COMPLETED
Standardized Lycium Chinense Fruit Extract Enhances Attention and Cognitive Function in Healthy Young People
Lead Sponsor:
Biomix
Collaborating Sponsors:
Kyunghee University
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
14-24 years
Phase:
NA
Brief Summary
Lycium chinense fruit (LCF) is widely distributed in East Asia that has been used traditionally for anti-aging purposes. This study was performed to examine the effects of LCF on attention and cogniti...
Detailed Description
The Computerized Neurocognitive function Test (CNT), the Korean version of the Attention-deficit/hyperactivity disorder (ADHD) Rating Scale-IV (K-ADHD-RS-IV), the Clinical Global Impression (CGI) rati...
Eligibility Criteria
Inclusion
- Age between 14 and 24 years old
- Male or female
- Ability to understand the objectives of the study and agreed to abide by the required rules during the study.
- If participants were aged between 14 and 20 years old, they and their parents had to provide informed consent.
Exclusion
- Diagnosis of ADHD (any subtype) according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria
- Diagnosis of a developmental disorder
- Pregnant or breastfeeding women and women with the possibility of getting pregnant
- Gastrointestinal disease or history of gastrointestinal surgery, which might affect the absorption of study materials
- Significant neurological (epilepsy, mental retardation, or stroke) or medical illnesses (diabetes, hypertension, or cardiovascular diseases),
- Participation in other clinical studies during the four weeks preceding the start of the study
- More than 1.5 times normal limit of ALT or AST.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2013
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT03439111
Start Date
November 1 2011
End Date
April 30 2013
Last Update
February 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biomix
Goyang-si, Gyeonggi-do, South Korea, 10442